Intrepid Potash (NYSE:IPI – Get Free Report) had its price target raised by equities researchers at UBS Group from $18.00 to $19.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “sell” rating on the basic materials company’s stock. UBS Group’s target price would indicate a potential downside of 33.77% from the stock’s current price.
Intrepid Potash Trading Up 7.4 %
IPI stock traded up $1.97 during trading on Tuesday, reaching $28.69. The stock had a trading volume of 189,454 shares, compared to its average volume of 88,995. Intrepid Potash has a 1-year low of $17.52 and a 1-year high of $29.10. The company has a market capitalization of $381.00 million, a P/E ratio of -7.61 and a beta of 2.18. The firm has a fifty day moving average price of $24.20 and a 200 day moving average price of $23.91.
Intrepid Potash (NYSE:IPI – Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The basic materials company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.25). Intrepid Potash had a negative return on equity of 2.02% and a negative net margin of 19.19%. The firm had revenue of $57.55 million during the quarter, compared to analyst estimates of $42.57 million. During the same quarter in the prior year, the firm earned ($0.53) EPS. Sell-side analysts predict that Intrepid Potash will post 0.27 EPS for the current year.
Institutional Investors Weigh In On Intrepid Potash
Intrepid Potash Company Profile
Intrepid Potash, Inc, together with its subsidiaries, engages in the extraction and production of the potash in the United States and internationally. It operates through three segments: Potash, Trio, and Oilfield Solutions. The company offers muriate of potash for various markets, such as agricultural market as a fertilizer input; the industrial market as a component in drilling and fracturing fluids for oil and gas wells, as well as an input to other industrial processes; and the animal feed market as a nutrient supplement.
See Also
- Five stocks we like better than Intrepid Potash
- Top Biotech Stocks: Exploring Innovation Opportunities
- Palantir Cracks $50, Is There Still Time to Get on Board?
- What Does a Stock Split Mean?
- Insider Buying Signals Upside for These 3 Stocks
- How to Buy Cheap Stocks Step by Step
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Intrepid Potash Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrepid Potash and related companies with MarketBeat.com's FREE daily email newsletter.